Aprea Therapeutics Inc (APRE)
5.40
-0.19
(-3.40%)
USD |
NASDAQ |
May 17, 16:00
5.40
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Investing (Quarterly): -0.008M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.008M |
| December 31, 2023 | -0.0072M |
| September 30, 2023 | -0.0859M |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0163M |
| September 30, 2020 | 0.0007M |
| June 30, 2020 | 0.002M |
| March 31, 2020 | -0.0122M |
| December 31, 2019 | -0.0145M |
| September 30, 2019 | -0.0102M |
| June 30, 2019 | -0.0062M |
| March 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0859M
Minimum
Sep 2023
0.002M
Maximum
Jun 2020
-0.0093M
Average
--
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 0.00 |
| Stoke Therapeutics Inc | 9.988M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.936M |
| Cash from Financing (Quarterly) | 14.71M |
| Free Cash Flow | -13.24M |
| Free Cash Flow Per Share (Quarterly) | -0.9394 |
| Free Cash Flow Yield | -65.22% |